A PRCI-Based Individualized Risk Prediction Model for Potentially Inappropriate Medication in Older Outpatients
- 1Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
Abstract
Objectives: Potentially inappropriate medication (PIM) use remains highly prevalent among older outpatients, yet individualized risk prediction tools are limited. This study aimed to develop and validate a PIM risk prediction model incorporating a novel disease-weighted index. Methods: A multicenter cross-sectional study was conducted using 131,894 outpatient prescriptions from 59 medical institutions in China. Diagnoses were mapped to ICD-10 codes. A PIM Risk-Related Comorbidity Index (PRCI) was developed using multivariable logistic regression and coefficient-weighted scoring. A prediction model was constructed and internally validated using a 6:4 split-sample approach. Discrimination, calibration, and clinical utility were assessed using ROC curves, calibration plots, and decision curve analysis. Results: The proportion of prescriptions containing at least one PIM was 29.0%. Polypharmacy showed a strong dose–response relationship with PIM risk. The PRCI was independently associated with PIM (OR = 1.07 per unit increase). The final model demonstrated good discrimination (AUC = 0.775 in training and 0.773 in validation), satisfactory calibration, and favorable clinical utility. A cutoff probability of 0.304 stratified prescriptions into high- and low-risk groups. Conclusions: The PRCI-based model provides an individualized and clinically applicable tool for identifying older outpatient prescriptions at high risk of containing PIMs, supporting proactive medication safety management.
Related
- Healthcare and cost burdens associated with potentially inappropriate medication use in older adults: a matched cohort study.
- Association Between Consulting Multiple Healthcare Facilities and Medication Burden Among Older Outpatients
- Medication Complexity and Insomnia Severity in Psychiatric Outpatients: A Moderation Analysis Across Mood and Non-Mood Disorders.
- Fusion of Deep Learning Radiomics and Clinical Features for Individualized Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma
- Time-varying risk prediction for oral potentially malignant disorders using deep learning
BibTeX
@article{chen2026prcibased,
title = {{A PRCI-Based Individualized Risk Prediction Model for Potentially Inappropriate Medication in Older Outpatients}},
author = {Zhaoyan Chen and Congjun Zhou and Yongfei Dong and Cairong Zhu},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15197675},
url = {https://www.mdpi.com/2077-0383/15/19/7675},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A PRCI-Based Individualized Risk Prediction Model for Potentially Inappropriate Medication in Older Outpatients
AU - Zhaoyan Chen
AU - Congjun Zhou
AU - Yongfei Dong
AU - Cairong Zhu
PY - 2026
DA - 2026/10/04
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15197675
UR - https://www.mdpi.com/2077-0383/15/19/7675
AB - Objectives: Potentially inappropriate medication (PIM) use remains highly prevalent among older outpatients, yet individualized risk prediction tools are limited. This study aimed to develop and validate a PIM risk prediction model incorporating a novel disease-weighted index. Methods: A multicenter cross-sectional study was conducted using 131,894 outpatient prescriptions from 59 medical institutions in China. Diagnoses were mapped to ICD-10 codes. A PIM Risk-Related Comorbidity Index (PRCI) was developed using multivariable logistic regression and coefficient-weighted scoring. A prediction model was constructed and internally validated using a 6:4 split-sample approach. Discrimination, calibration, and clinical utility were assessed using ROC curves, calibration plots, and decision curve analysis. Results: The proportion of prescriptions containing at least one PIM was 29.0%. Polypharmacy showed a strong dose–response relationship with PIM risk. The PRCI was independently associated with PIM (OR = 1.07 per unit increase). The final model demonstrated good discrimination (AUC = 0.775 in training and 0.773 in validation), satisfactory calibration, and favorable clinical utility. A cutoff probability of 0.304 stratified prescriptions into high- and low-risk groups. Conclusions: The PRCI-based model provides an individualized and clinically applicable tool for identifying older outpatient prescriptions at high risk of containing PIMs, supporting proactive medication safety management.
SN - 2077-0383
ER -